
Liquidia Corp Investor Relations Material
Latest events

Status Update
Liquidia Corp
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Liquidia Corp
Access all reports
Liquidia Corp. is a biopharmaceutical company focused on developing and commercializing innovative therapies for pulmonary and other rare diseases. The company utilizes its proprietary PRINT technology to engineer precise drug particles designed to improve the delivery and efficacy of inhaled treatments. Liquidia's primary focus is on addressing unmet medical needs in pulmonary arterial hypertension (PAH) and other related conditions. The company is involved in advancing its therapies through clinical trials and regulatory approvals, aiming to provide improved treatment options for patients with chronic, life-threatening illnesses. The company is headquartered in Morrisville, North Carolina, and its shares are listed on the NASDAQ.
Key slides for Liquidia Corp


43rd Annual J.P. Morgan Healthcare Conference 2025
Liquidia Corp


Status Update
Liquidia Corp
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
LQDA
Country
🇺🇸 United States